VRDN viridiantherapeutics.com: Prakiraan wutah bathi saben saham kanggo taun ngarep

Logo perusahaan publik Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics (VRDN) is implementing ESG principles by reducing energy consumption and plastic waste in its laboratories. Shifting analyst expectations for EPS growth in year n+1 reflect forecast dynamics where the 41.70 level represents the current value. The asset serves as a defensive tool due to stable demand for ophthalmology. Meanwhile, drug synthesis is accelerating through the application of artificial intelligence algorithms.

VRDN: Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Viridian Pharma 04.07.2022 - 16.11.2026

VRDN (Viridian Therapeutics, Inc.): rincian analitis lan laporan miturut indikator

Analisis umum perusahaan:viridiantherapeutics.com, VRDN
Produk dadi viridiantherapeutics.com

This indicator reflects the analysts' consensus estimate regarding the growth rate of earnings per share (EPS) for the next fiscal period, allowing for the identification of a fundamental overvaluation or undervaluation of the asset. By analyzing the forward EPS growth forecast, an investor can compare market expectations with the management competencies of Viridian Therapeutics (VRDN) regarding the acceleration of clinical trials and the transparency of their reporting.

Analisis pesaing

ALC (Alcon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Bausch + Lomb Corporation (BLCO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GKOS|Prakiraan wutah bathi kanggo taun ngarep Apellis Pharmaceuticals, Inc. (APLS)|Prakiraan wutah bathi kanggo taun ngarep BLTE (Belite Bio)|OCUL - Prakiraan wutah bathi saben saham kanggo taun ngarep|HROW - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LENZ (LENZ Therapeutics) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Oculis (OCS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep EYPT (EyePoint Pharmaceuticals Inc)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kodiak Sciences Inc|Prakiraan wutah bathi resik saben saham ing taun ngarep aldeyra.com ALDX|Prakiraan wutah bathi kanggo taun ngarep KALA|IRD - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OKYO (OKYO Pharma Limited)|ADVM - Prakiraan wutah bathi saben saham kanggo taun ngarep|OTLK: Prakiraan wutah bathi saben saham kanggo taun ngarep|CLSD (Clearside) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NBY: Prakiraan wutah bathi kanggo taun ngarep|Kiora Pharma (KPRX) - Prakiraan wutah bathi kanggo taun ngarep|ALIM (alimerasciences.com) - Prakiraan wutah bathi kanggo taun ngarep|eyenovia.com (EYEN) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GHSI|OCUP (Ocuphire) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OPT (Opthea Ltd)